InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
28%
T+90 mean return
-2.1%
Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by CAUSEY CHRISTOPHER, Director. Officer active across 1 company, notably UNITED THERAPEUTICS Corp. Aggregated, 29 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €1.4m. History available since 26 May 2021. The latest transaction was filed on 9 September 2024 (Don). Regulator: SEC (Form 4). All data is openly available.
Declarations29 total
225 shares0Common StockSEC:0001237334-25-000005
225 shares0Common StockSEC:0001237334-25-000005:0
510 shares@ US$376.62813.4% of flowCommon StockSEC:0001415889-24-025976:0
1,210 shares@ US$132.302.7% of flowCommon StockSEC:0001415889-24-022034:0
3,000 shares@ US$112.146.0% of flowCommon StockSEC:0001415889-24-017646:0
2,000 shares@ US$112.144.0% of flowCommon StockSEC:0001415889-24-016933:0
2,000 shares@ US$112.143.9% of flowCommon StockSEC:0001415889-24-013353:0
2,240 shares@ US$112.144.4% of flowCommon StockSEC:0001415889-24-012329:0
400 shares@ US$255.001.8% of flowCommon StockSEC:0001415889-23-016597:0
3,000 shares@ US$175.439.3% of flowCommon StockSEC:0001415889-23-016417:0
1,750 shares0Common StockSEC:0001415889-23-010945:0
1,000 shares@ US$175.433.1% of flowCommon StockSEC:0001415889-23-000085:0
2,500 shares@ US$175.438.4% of flowCommon StockSEC:0001415889-22-011052:0
3,500 shares@ US$175.4311.7% of flowCommon StockSEC:0001415889-22-009057:0
2,160 shares0Common StockSEC:0001415889-22-007607:0
5,000 shares@ US$236.7921.3% of flowCommon StockSEC:0001415889-22-007024:1
5,000 shares@ US$76.360.0015% mcap34.3% of flowCommon StockSEC:0001415889-22-007024:0
75 shares0Common StockSEC:0001415889-22-005904:0
5,000 shares@ US$76.360.0015% mcap33.8% of flowCommon StockSEC:0001415889-22-005700:0
2,610 shares@ US$76.360.0007% mcap16.0% of flowCommon StockSEC:0001127602-21-023274:0
2,610 shares@ US$76.363.2% of flowCommon StockSEC:0001127602-21-023274
75 shares0Common StockSEC:0001127602-21-018328
75 shares0Common StockSEC:0001127602-21-018328:0
750 sharesCommon StockSEC:0001127602-16-040054:0
750 sharesCommon StockSEC:0001127602-16-040054:1
25 of 29 declarations
About CAUSEY CHRISTOPHER
Christopher Causey is a Director at United Therapeutics Corp. In this role, he participates in the governance of the company and contributes to strategic decision-making. His experience is valuable in guiding the company in its growth initiatives.
